The Impact of Late Effects After Treatment for Bladder Cancer on Quality of Life

Bladder Cancer prognosis, treatment, and subsequent morbidity and mortality vary between the different stages, thus resulting in a different impact on patients' lives. There are some well known late effects of the treatments for bladder cancer, but the knowledge of their impact on patients Quality of Life is sparse. This study aims to determine the prevalence of late effects impact on Quality of Life and potential risk factors for impairment.

Enrolling by Invitation

Interested in participating?

Request Info

Key information

Conditions

Bladder Cancer Female Urogenital Diseases Female Urogenital Diseases and Pregnancy Complications Male Urogenital Diseases Neoplasms Neoplasms by Site Urinary Bladder Diseases Urinary Bladder Neoplasms Urogenital Diseases Urogenital Neoplasms Urologic Diseases Urologic Neoplasms

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Department of Urology, Aarhus University Hospital, Aarhus N, Denmark

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Patients are eligible if they are referred to a hospital in the Central Region Denmark, due to hematuria between 01/01/2022 and 01/01/2023
Ability to understand written and oral Danish

Exclusion criteria

Known Alzheimers disease
Diagnosed other causes explaining the hematuria

Treatment and study plan

Primary outcomes

Health-related Quality of Life

Time frame: 5 years from baseline inclusion

Changes in Quality of Life measured using validated instruments

Secondary outcomes

Prevalence of late effects

Time frame: 5 years from baseline inclusion

Based on Patient Reported Outcomes and medical records

Sponsors and collaborators

Lead sponsor

Aarhus University Hospital

Other

Collaborators

National Research Center for Survivorship and Late Adverse Effects Following Pelvic Organ Cancer, Denmark
University of Aarhus

Registry information

Official study title

The Impact of Late Effects After Treatment for Bladder Cancer on Quality of Life - What is the Cost of the Cure?

Acronym: CONQUER

Important dates

Study start: 2022
Primary completion: 2027
Study completion: 2027
First posted: Jan 19, 2022
Registry last updated: Mar 3, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Enrolling by Invitation